Cargando…
PB2320: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONG THE ELDERLY: A TUNISIAN MULTICENTER EXPERIENCE.
Autores principales: | Zahra, Kmira, Belaid, Imtinène, Kacem, Karima, Elloumi, Moez, Mezlini, Amel, Msaddek, Fehmi, Tarek, Ben Othman, Nabil, Toumi, Lakhal, Raihane Ben, Khelif, Abderrahim, Slim, Ben Ahmed, Afef, Khanfir, Laatiri, Adnene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429590/ http://dx.doi.org/10.1097/01.HS9.0000976000.63914.af |
Ejemplares similares
-
PB2340: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONGPATIENTS AGED LESS THAN 60 YEARS: A TUNISIAN MULTICENTER EXPERIENCE.
por: Zahra, Kmira, et al.
Publicado: (2023) -
Assessment of depression, anxiety and fatigue in Tunisian patients in recovery from colon cancer and their impact on quality of life
por: Chamsi, Amal, et al.
Publicado: (2022) -
Treatment of Acute Promyelocytic Leukemia with AIDA Based Regimen. Update of a Tunisian Single Center Study
por: Jeddi, Ramzi, et al.
Publicado: (2011) -
PB2312: REACTIVATION OF HEPATITIS B VIRUS FOLLOWING RITUXIMAB IN B LYMPHOID HEMOPATHIES
por: Wafa, Miled, et al.
Publicado: (2023) -
PB2368: THE PRE-EMPTIVE STRATEGY OF HEPATITIS B VIRAL REACTIVATION IN PATIENTS WITH MALIGNANT HEMOPATHIES RECEIVING IMMUNSUPPRESSIVE THERAPY IN TUNISIA
por: Wafa, Miled, et al.
Publicado: (2023)